Written by Damjan Denoble.
Posted on February 3, 2010.
Filed under China, Marketing Health, News Items.
Unlike physicians in the US, Chinese physicians have long gotten used to depending on drug sales for the majority of their pay check. State provided salaries are small, and hospital oversight is opaque enough to make under the table payments from drug sales reps easy, and widespread. With the new Essential Drug List that was finalized this past summer, under the table payments are going to be much hard to make because and overwhelming percentage of the most profitable drugs are going to be sold exclusively at rural hospitals for a flat fee. The new reality will involve a lot more 'feet on the ground' because of where the most drugs are being sold (rural pharmacies) and because it will now take more time to persuade doctors that a particular product is the best product. This is where Pfizer is ahead of the curve
Written by Damjan Denoble.
Posted on October 13, 2009.
Filed under China, Marketing Health.
Posted By Damjan DeNoble
I came across this China Hush post (a blog which is growing on me by the day) on HaoHao Report (a great “best of” China blog story aggregator site) that highlights 10 of the most annoying and misleading commercials that aired on Chinese television in the past year. You can check it [...]
China Healthcare Blog
Pfizer’s China Strategy shows why they are still alive in the Big Pharma Consolidation Wars